Correlation Between Norman Broadbent and Tissue Regenix

Can any of the company-specific risk be diversified away by investing in both Norman Broadbent and Tissue Regenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Norman Broadbent and Tissue Regenix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Norman Broadbent Plc and Tissue Regenix Group, you can compare the effects of market volatilities on Norman Broadbent and Tissue Regenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Norman Broadbent with a short position of Tissue Regenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Norman Broadbent and Tissue Regenix.

Diversification Opportunities for Norman Broadbent and Tissue Regenix

-0.27

Correlation Coefficient

Norman Broadbent  Tissue Regenix

Very good diversification

The 3 months correlation between Norman and Tissue is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Norman Broadbent Plc and Tissue Regenix Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tissue Regenix Group and Norman Broadbent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Norman Broadbent Plc are associated (or correlated) with Tissue Regenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tissue Regenix Group has no effect on the direction of Norman Broadbent i.e., Norman Broadbent and Tissue Regenix go up and down completely randomly.

Pair Corralation between Norman Broadbent and Tissue Regenix

Assuming the 90 days trading horizon Norman Broadbent Plc is expected to generate 1.81 times more return on investment than Tissue Regenix. However, Norman Broadbent is 1.81 times more volatile than Tissue Regenix Group. It trades about 0.01 of its potential returns per unit of risk. Tissue Regenix Group is currently generating about -0.01 per unit of risk. If you would invest  350.00  in Norman Broadbent Plc on October 10, 2024 and sell it today you would lose (25.00) from holding Norman Broadbent Plc or give up 7.14% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Norman Broadbent Plc  vs.  Tissue Regenix Group

Norman Broadbent Plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Norman Broadbent Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Tissue Regenix Group

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Tissue Regenix Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Tissue Regenix may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Norman Broadbent and Tissue Regenix

The main advantage of trading using opposite Norman Broadbent and Tissue Regenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Norman Broadbent position performs unexpectedly, Tissue Regenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tissue Regenix will offset losses from the drop in Tissue Regenix's long position.

The idea behind Norman Broadbent Plc and Tissue Regenix Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.